We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Autonomix, we¿re developing a two-fold technology that can both detect malfunctioning neural signals and ablate nerves in one simple procedure for pain management. This opens us up to a world of possibilities in the field of electrophysiology. Clinical trials start this year for the treatment of pan... Autonomix, we¿re developing a two-fold technology that can both detect malfunctioning neural signals and ablate nerves in one simple procedure for pain management. This opens us up to a world of possibilities in the field of electrophysiology. Clinical trials start this year for the treatment of pancreatic cancer pain and pancreatitis pain. Show more
Management to host live webcast to discuss results on Tuesday, June 18th at 8:30 a.m. ET THE WOODLANDS, TX, June 10, 2024 (GLOBE NEWSWIRE) -- – Autonomix Medical, Inc. (NASDAQ: AMIX...
Company plans to release topline results from “lead-in” patients (n=5) imminently THE WOODLANDS, TX, June 03, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the...
Year marked by operational and clinical execution advancing the development of a potential breakthrough technology for the nervous system Continued progress in first study ever to evaluate...
Results from the preclinical study demonstrated statistically significant reduction of metastases and statistically significant reduction in tumor mass Lori Bisson, Chief Executive Officer...
Live webcast on Thursday, May 16th at 4:00 PM ET THE WOODLANDS, TX, May 14, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device...
THE WOODLANDS, TX, April 25, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies...
Live webcast on Wednesday, May 1st at 3:20 PM ET THE WOODLANDS, TX, April 24, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.33 | -18.4357541899 | 1.79 | 1.79 | 1.13 | 153756 | 1.36431181 | CS |
| 4 | -1.04 | -41.6 | 2.5 | 2.8 | 1.13 | 101372 | 1.83649559 | CS |
| 12 | -1.78 | -54.9382716049 | 3.24 | 3.79 | 1.13 | 61863 | 2.32013341 | CS |
| 26 | -6.14 | -80.7894736842 | 7.6 | 7.6 | 1.13 | 69948 | 3.27367198 | CS |
| 52 | -6.14 | -80.7894736842 | 7.6 | 7.6 | 1.13 | 69948 | 3.27367198 | CS |
| 156 | -6.14 | -80.7894736842 | 7.6 | 7.6 | 1.13 | 69948 | 3.27367198 | CS |
| 260 | -6.14 | -80.7894736842 | 7.6 | 7.6 | 1.13 | 69948 | 3.27367198 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
